- This event has passed.
Bioethics Webinar: Direct-to-consumer advertising of drugs: should we change it, and if so, how?
November 10, 2016, 6:30 pm - 8:00 pm
The Columbia University Bioethics program is pleased to host a series of online webinars examining critical ethical and policy issues that arise in the context of drug and device development and the pharmaceutical industry. Our first webinar will focus on ethical questions posed by Direct-to-Consumer (DTC) pharmaceutical advertising.
The United States and New Zealand are the only countries that allow DTC pharmaceutical advertising. Supporters of DTC ads say that these educate consumers and raise awareness of diseases. But others have concerns about the ads, and call for increased regulation. What should be done?
Dr. Robert Klitzman will moderate a discussion on these timely and important ethical questions regarding DTC advertising with a panel of distinguished speakers.
SPEAKERS
Richard Meyer, former Eli Lilly marketing executive; current pharmaceutical consultant
Richard Kravitz, MD, MSPH, Professor and Co-vice Chair of Research, Department of Internal Medicine, UC Davis
Tony Russo, Ph.D., Chairman and CEO, Russo Partners LLC
Ed Silverman, Senior Writer and Pharmalot columnist, STAT News
Diana Zuckerman, Ph.D., President, National Center for Health Research
This event is an online webinar. Please register here.
